Director, Quality - GCP (Contract)

Company introduction: Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is headquartered in London, UK, with offices in New York City in the US. We focus on developing novel treatments that have the potential to improve the lives of those who are suffering with mental health conditions and who are not helped by current treatments.

We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational COMP360 synthetic psilocybin treatment, potentially a first in class treatment. COMP360 has Breakthrough Therapy designation from the US Food and Drug Administration (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the UK for treatment-resistant depression (TRD) due to the pressing unmet need in this area. We are currently in phase 3 for TRD, have completed phase 2 studies for both post-traumatic stress disorder (PTSD) and anorexia nervosa and are planning a further late-stage study in PTSD.

We envision a world where mental health means not just the absence of illness but the ability to thrive. - Compass Pathways . Job overview: The Director of Clinical Quality Assurance (GCP) serves as the enterprise GCP QA expert across the Compass organization, providing strategic leadership and oversight of clinical quality systems, audit programs, and compliance frameworks.

This role is accountable for ensuring the design, implementation, and continuous improvement of a robust, risk-based GCP Quality Assurance function that supports the full clinical development lifecycle.

Requirements

, with a strong focus on subject safety, data integrity, and inspection readiness. The role operates with a high degree of independence, providing objective quality oversight and driving a culture of proactive quality and continuous improvement. Reports to: VP, Quality.

Location: United Kingdom (Home-based or office-based/hybrid in our London office). Duration: 6 -month contract.

Audit Inspection Management Design and lead a comprehensive, risk-based GCP audit program covering: Investigator sites, CROs and vendors, Internal systems, processes, and databases Ensure audits are executed in compliance with global GCP regulations and internal standards Lead inspection readiness activities and act as a key Quality representative during regulatory inspections Oversee timely closure and effectiveness of audit and inspection CAPAs Risk Compliance Oversight Assess and interpret audit findings, deviations, and compliance risks with respect to: Subject safety, Data integrity, Regulatory impact Escalate critical and systemic risks to senior leadership with clear mitigation strategies Lead and oversee investigations into: Significant quality issues, Scientific misconduct., Serious breaches of GCP Ensure robust root cause analysis and sustainable CAPA implementation Cross-Functional Partnership Act as the primary GCP QA advisor to R D and external p

Responsibilities (Include But Are Not Limited To)

: Strategy Leadership Define and execute the global GCP QA strategy aligned with organizational and clinical development objectives Build and scale GCP QA capabilities to support the clinical portfolio Maintain strong independence of the QA function while effectively influencing stakeholders across R D Champion a proactive, risk-based quality culture across the organization GCP Quality Systems Governance Establish, maintain, and continuously improve GCP QA processes, procedures, and governance frameworks Ensure effectiveness of key quality systems (deviations, CAPA, change control, training, document management) in a GCP environment Provide expert guidance on regulatory expectations and evolving GCP